Haploidentical stem cell transplantation in newly diagnosed high-risk neuroblastoma: Results from a single-arm, prospective study from India
Children with high-risk neuroblastoma continued to relapse within a year post-HSCT in our cohort. Significant improvement in outcomes was not demonstrated with haploidentical HSCT. We urgently need new strategies including deeper remission induction with upfront metaiodobenzylguanidine (MIBG) therapy followed by HSCT to improve the outcomes.
Authors
- Revathi Raj (ORCID: https://orcid.org/0000-0003-1415-4142)
- Rumesh Chandar (ORCID: https://orcid.org/0000-0002-0761-3411)
- Ramya Uppuluri (ORCID: https://orcid.org/0000-0001-5771-8214)
- Harika Varla (ORCID: https://orcid.org/0000-0002-0991-3493)
- Venkateswaran Venkateswaran Swaminathan
- Satishkumar Meena (ORCID: https://orcid.org/0000-0002-9407-2034)
Institutions
- Apollo Hospitals (IN)
Publication Details
- Journal
- Indian Journal of Cancer
- Published
- 2025-01-01
- DOI
- https://doi.org/10.4103/ijc.ijc_999_21
- Citations
- 1
- Primary Topic
- Neuroblastoma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.39